公开(公告)号：WO2022126275A1

公开(公告)日：2022-06-23

申请号：PCT/CA2021/051826

申请日：2021-12-16

Applicant: THE UNIVERSITY OF BRITISH COLUMBIA ,  PROVINCIAL HEALTH SERVICES AUTHORITY ,  ALPHA-9 THERANOSTICS INC. ,  BÉNARD, François ,  LIN, Kuo-shyan ,  ZHANG, Chengcheng ,  PERRIN, David ,  ROXIN, Aron ,  ZHANG, Zhengxing ,  DOUCHEZ, Antoine ,  DANESHMANDKASHANI, Pargol ,  LAI, Samson

Inventor： BÉNARD, François ,  LIN, Kuo-shyan ,  ZHANG, Chengcheng ,  PERRIN, David ,  ROXIN, Aron ,  ZHANG, Zhengxing ,  DOUCHEZ, Antoine ,  DANESHMANDKASHANI, Pargol ,  LAI, Samson

IPC: C07D257/02 ,  A61K51/04 ,  A61K51/08 ,  C07K5/06 ,  C07K5/037

Abstract: The present invention relates to radiolabelled compounds for in vivo imaging or treatment of diseases or conditions characterized by expression of prostate-specific membrane antigen.